959 related articles for article (PubMed ID: 18166509)
1. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
2. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
3. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
5. High physiological prolactin induced by pituitary transplantation decreases BMD and BMC in the femoral metaphysis, but not in the diaphysis of adult female rats.
Thongchote K; Charoenphandhu N; Krishnamra N
J Physiol Sci; 2008 Feb; 58(1):39-45. PubMed ID: 18198010
[TBL] [Abstract][Full Text] [Related]
6. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
7. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
[TBL] [Abstract][Full Text] [Related]
8. Prolactin decreases the expression ratio of receptor activator of nuclear factor kappaB ligand/osteoprotegerin in human fetal osteoblast cells.
Seriwatanachai D; Charoenphandhu N; Suthiphongchai T; Krishnamra N
Cell Biol Int; 2008 Sep; 32(9):1126-35. PubMed ID: 18556224
[TBL] [Abstract][Full Text] [Related]
9. Bone modeling in bromocriptine-treated pregnant and lactating rats: possible osteoregulatory role of prolactin in lactation.
Suntornsaratoon P; Wongdee K; Goswami S; Krishnamra N; Charoenphandhu N
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E426-36. PubMed ID: 20551289
[TBL] [Abstract][Full Text] [Related]
10. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
12. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
13. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
14. Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells.
Nuntapornsak A; Wongdee K; Thongbunchoo J; Krishnamra N; Charoenphandhu N
Cell Biochem Funct; 2010 Jan; 28(1):45-51. PubMed ID: 19827007
[TBL] [Abstract][Full Text] [Related]
15. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
17. Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene.
Luvizuto ER; Queiroz TP; Dias SM; Okamoto T; Dornelles RC; Garcia IR; Okamoto R
Arch Oral Biol; 2010 Jan; 55(1):52-9. PubMed ID: 19948337
[TBL] [Abstract][Full Text] [Related]
18. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
[TBL] [Abstract][Full Text] [Related]
19. Alteration of bone cell function by RANKL and OPG in different in vitro models.
Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
[TBL] [Abstract][Full Text] [Related]
20. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
Horner KC
Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]